Light Mode
$61.46 ↑ +0.00 (+0.00%) Trading Up from the previous close of $61.46, $2.48 below the day’s high of $63.94
+2.73 (+4.65%) / 6M
Momentum, market sentiment, and recent alerts
PCVX reads not so good: price sits above one of the two key moving averages, the 12-month move is +37.9%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.